Mostrar el registro sencillo del ítem

dc.rights.licensehttp://creativecommons.org/licenses/by-nc-nd/4.0es_MX
dc.creatorSANTIAGO PAULINO RAMIREZ DIAZes_MX
dc.creatorGuillermo Albert Mezaes_MX
dc.creatorRodolfo Emmanuel Albrecht Junghannses_MX
dc.creatorClemente Humberto Zuñiga Giles_MX
dc.creatorMa. de los Auxilios Rafaela Bendia Reyeses_MX
dc.creatorLEONARDO ALBERTO BARBA VALADEZes_MX
dc.creatorEmmanuel Almanza Huantees_MX
dc.creatorLEONARDO ELEAZAR CRUZ ALCALAes_MX
dc.date2015
dc.date.accessioned2021-12-02T19:04:40Z
dc.date.available2021-12-02T19:04:40Z
dc.identifier.urihttp://repositorio.inger.gob.mx/jspui/handle/20.500.12100/17319
dc.descriptionObjective: To know the current status of the clinical assessment tests used to evaluate Alzheimer’s disease (AD) and memory-related dementias in specific regions throughout Mexico. Design, patients and settings: Patients with objective memory impairment were subjected to a clinical survey in medical centers specializing in memory loss. Each patient’s consultation was conducted like a routine clinical practice. Patient’s data were recorded using an anonymous patient survey. The most prominent behavioral problems were recorded. Results: 1350 patients were tested, 65.19% female (n=880). Out of 1350 patients, 76.59% (n=1034) had been previously diagnosed with any kind of dementia. The most common diagnosis concerning cognitive impairment was AD (54.2%, n=560) and Vascular Dementia (VaD, 19.7%, n=204). Minimental State Examination (MMSE) was performed in all patients and the average score was of 18±7. Katz scale for Activities of Daily Living (ADL) was performed in 49.41% (n=667) of patients, Lawton and Brody scale for Instrumental activities of daily living (IADL) in 35.78% (n=483), and Geriatric Depression Scale (GDS-Yesavage) in 32.89% (n=444). The most prominent behavioral symptom was apathy (12.15%, n=164).The most frequent concomitant diseases were: high blood pressure in 52.3%, diabetes in 27.0% and Dyslipidemia in 23.4%. Conclusions: Through the assessment of clinical surveys throughout Mexico, it was found that the most common form of dementia is AD and it is followed by VaD. Commonly, the Katz, Lawton and Brody, and the GDS-Yesavage scales are clinical assessment tests that are the most commonly used. There are many differences in the use of tests to evaluate patients with dementia across Mexico. For the first time, we were able to identify tendencies in the assessment of dementias by Mexican physicians.es_MX
dc.formatAdobe PDFes_MX
dc.languageenges_MX
dc.publisherJARLIFEes_MX
dc.relationhttps://www.jarlife.net/all-issues.html?article=258es_MX
dc.relation.requiresSies_MX
dc.rightsAcceso Abiertoes_MX
dc.sourceJournal of Aging Research & Clinical Practice (2273-421X) Vol. 4 (2015)es_MX
dc.subjectMEDICINA Y CIENCIAS DE LA SALUDes_MX
dc.subjectCiencias médicases_MX
dc.subjectCiencias clínicases_MX
dc.subjectGeriatríaes_MX
dc.subjectDisfunción cognitivaes_MX
dc.subjectCognitive dysfunctiones_MX
dc.subjectDemenciaes_MX
dc.subjectDementiaes_MX
dc.subjectEnfermedad de Alzheimeres_MX
dc.subjectAlzheimer´s diseasees_MX
dc.subjectMéxicoes_MX
dc.subjectMexicoes_MX
dc.titleAn overview on assessment tests for alzheimer’s disease in Mexico. The national dementia survey: a study from the mexican group of specialists in dementiases_MX
dc.typeArtículoes_MX
dc.audienceResearcherses_MX
dc.creator.idRADS710915HDFMZN08es_MX
dc.creator.idCA1219311es_MX
dc.creator.idCA1219034es_MX
dc.creator.idCA1219384es_MX
dc.creator.idCA1350225es_MX
dc.creator.idBAVL900811HASRLN09es_MX
dc.creator.idCA1219142es_MX
dc.creator.idCUAL560823HJCRLN05es_MX
dc.creator.nameIdentifiercurpes_MX
dc.creator.nameIdentifiercaes_MX
dc.creator.nameIdentifiercaes_MX
dc.creator.nameIdentifiercaes_MX
dc.creator.nameIdentifiercaes_MX
dc.creator.nameIdentifiercurpes_MX
dc.creator.nameIdentifiercaes_MX
dc.creator.nameIdentifiercurpes_MX


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem